1999
DOI: 10.1006/mgme.1999.2808
|View full text |Cite
|
Sign up to set email alerts
|

Progress in Neuropathology of the Neuronal Ceroid Lipofuscinoses

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
21
0

Year Published

2003
2003
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 31 publications
(21 citation statements)
references
References 20 publications
0
21
0
Order By: Relevance
“…Immunohistochemical staining for the glial cell marker GFAP in brain and spinal cord sections revealed substantial gliosis in cat F Ϫ/Ϫ mice compared to agematched WT controls (Fig. 4B), which indicates neuronal stress or neurodegeneration (9) and which occurs in NCL patients and mouse models (21,38). Quantification of GFAP staining in four matched regions of the cortex and spinal cord demonstrated an average of ϳ6.7-fold increase in gliosis in cat (Fig.…”
Section: Resultsmentioning
confidence: 94%
See 1 more Smart Citation
“…Immunohistochemical staining for the glial cell marker GFAP in brain and spinal cord sections revealed substantial gliosis in cat F Ϫ/Ϫ mice compared to agematched WT controls (Fig. 4B), which indicates neuronal stress or neurodegeneration (9) and which occurs in NCL patients and mouse models (21,38). Quantification of GFAP staining in four matched regions of the cortex and spinal cord demonstrated an average of ϳ6.7-fold increase in gliosis in cat (Fig.…”
Section: Resultsmentioning
confidence: 94%
“…Thus far, there has been little insight into the possible pathobiology of adult-onset NCL, although a few cases are caused by mild mutations of the PPT1 gene (39), and known NCL genes have been excluded by sequencing in some patients (S. E. Mole, unpublished data). The heterogeneity of clinical presentations of late-onset disease suggests that more than one gene is likely involved (9). Several naturally occurring animal models exist that appear to represent late-onset NCLs, but thus far the underlying genetic defects have also not been identified in these (5,27,30,34).…”
Section: Discussionmentioning
confidence: 99%
“…The NCL share clinical manifestations, biochemistry, and pathology, hence their classification together (5)(6)(7)(8)(9)(10)(11)(12)(13)(14). It is probable that all of the NCL genes belong to a common metabolic pathway (15).…”
Section: Discussionmentioning
confidence: 99%
“…The clinical features include loss of vision, seizures, and mental and motor deterioration. Depending on the affected gene, the clinical signs become visible at various developmental stages (1). Currently, eight forms of human NCLs (CLN1-8) can be differentiated for which six underlying genes have been identified (2).…”
mentioning
confidence: 99%